Clinical and Genetic Atrial Fibrillation Risk and Discrimination of Cardioembolic From Noncardioembolic Stroke
Authors:
- Lu-Chen WengLWLu-Chen Weng
- Shaan KhurshidSKShaan Khurshid
- Sophia GunnSGSophia Gunn
- Ludovic TrinquartLTLudovic Trinquart
- Kathryn L. LunettaKLKathryn L. Lunetta
- Huichun XuHXHuichun Xu
- Ninds Stroke Genetics NetworkNNNinds Stroke Genetics Network
- Emelia J. BenjaminEmelia J. Benjamin
- Patrick T. EllinorPEPatrick T. Ellinor
- Christopher D. AndersonCAChristopher D. Anderson
- Steven A. LubitzSLSteven A. Lubitz
- 1 July 2023
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 54 (7) , 1777-1785
Abstract
BACKGROUND: Stroke is a leading cause of death and disability worldwide. Atrial fibrillation (AF) is a common cause of stroke but may not be detectable at the time of stroke. We hypothesized that an AF polygenic risk score (PRS) can discriminate between cardioembolic stroke and noncardioembolic strokes. METHODS: We evaluated AF and stroke risk in 26 145 individuals of European descent from the Stroke Genetics Network case-control study. AF genetic risk was estimated using 3 recently developed PRS methods (LDpred-funct-inf, sBayesR, and PRS-CS) and 2 previously validated PRSs. We performed logistic regression of each AF PRS on AF status and separately cardioembolic stroke, adjusting for clinical risk score (CRS), imputation group, and principal components. We calculated model discrimination of AF and cardioembolic stroke using the concordance statistic (c-statistic) and compared c-statistics using 2000-iteration bootstrapping. We also assessed reclassification of cardioembolic stroke with the addition of PRS to either CRS or a modified CHA 2 DS 2 -VASc score alone. RESULTS: Each AF PRS was significantly associated with AF and with cardioembolic stroke after adjustment for CRS. Addition of each AF PRS significantly improved discrimination as compared with CRS alone ( P P + =14% [95% CI, 10%–18%]; nonevent reclassification [net reclassification indices] − =17% [95% CI, 15%–0.19%]) or the modified CHA 2 DS 2 -VASc score (net reclassification indices + =11% [95% CI, 7%–15%]; net reclassification indices − =14% [95% CI, 12%–16%]) alone. CONCLUSIONS: Addition of polygenic risk of AF to clinical risk factors modestly improves the discrimination of cardioembolic from noncardioembolic strokes, as well as reclassification of stroke subtype. Polygenic risk of AF may be a useful biomarker for identifying strokes caused by AF.Keywords
This publication has 51 references indexed in Scilit:
- Simple Risk Model Predicts Incidence of Atrial Fibrillation in a Racially and Geographically Diverse Population: the CHARGE‐AF ConsortiumJournal of the American Heart Association, 2013
- Novel genetic markers improve measures of atrial fibrillation risk predictionEuropean Heart Journal, 2013
- Subclinical Atrial Fibrillation and the Risk of StrokeNew England Journal of Medicine, 2012
- Prolonged Rhythm Monitoring for the Detection of Occult Paroxysmal Atrial Fibrillation in Ischemic Stroke of Unknown CauseCirculation, 2011
- The Causative Classification of Stroke systemNeurology, 2010
- Electrocardiographic predictors of atrial fibrillationAmerican Heart Journal, 2009
- A Computerized Algorithm for Etiologic Classification of Ischemic StrokeStroke, 2007
- Comparison of Warfarin and Aspirin for Symptomatic Intracranial Arterial StenosisNew England Journal of Medicine, 2005
- Effect of Intensity of Oral Anticoagulation on Stroke Severity and Mortality in Atrial FibrillationNew England Journal of Medicine, 2003
- Stroke Severity in Atrial FibrillationStroke, 1996